DRUG DISCOVERY SOLUTIONS

Posts by Steve Trim

Metrion Biosciences and Venomtech announce research collaboration

Collaboration to search for novel modulators of ion channels with proven therapeutic potential Cambridge, UK, 24 April 2017: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, and Venomtech Limited (Venomtech) a biotechnology company with the UK’s largest venom library, today announced a collaboration agreement which will see the two companies…

Read More

Venomtech’s 7th birthday – founder’s blog 

A seventh birthday is not a traditional milestone but in an industry where less than 10% survive every year it is worth celebrating. It’s also a good time to reflect on the origins, that spark off an idea that launched a company that is back on the very pharmaceutical site that spawned the idea. Initially…

Read More

Venomtech and Mibelle Biochemistry announce the launch of soothing venom peptide for sensitive skin preparations 

A novel active ingredient inspired by nature from under the sea In the never-ending search for interesting new sources for active ingredients, much of the attention these days has shifted towards ingredients of marine origin. Many marine species have not yet been extensively studied. This makes new findings that propose beneficial effects for us highly…

Read More

Featured in Laboratory News October16 Edition

Why are so many drugs derived from natural sources on the market to treat human disease? Venom-master Steve Trim explains how evolution can give us a pharmaceutical short-cut http://www.labnews.co.uk/features/doesnt-kill-us-13-10-2016/

Read More